Clinical Trial Report

The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study

Jalihal U, Nanda RA, Katariya K, Ramanathan B, Kumawat R

Hepatic Medicine: Evidence and Research 2025, 17:61-73

Published Date: 1 August 2025